BioSpace News Archive

Please be advised that the Honourable Seamus O’Regan, Minister of Indigenous Services, alongside Chief Rudy Turtle of Grassy Narrows First Nation, will sign a Memorandum of Agreement outlining a path forward to meet the long-term health needs of the community which has been impacted by exposure to mercury.

Amgen (NASDAQ: AMGN), along with leading community oncology networks, today announced the launch of Amgen Community Oncology Research Collaborators (ACORC), a new initiative to enhance access by community centers to innovative oncology clinical research

Lyra Therapeutics, Inc., a clinical-stage biotechnology company developing medicines precisely designed to target ear, nose and throat (ENT) diseases, today announced that the company will present at the Jefferies 2019 Global Healthcare Conference on Tuesday, June 4, 2019, at 9:00 a.m. ET

Starpharma (ASX: SPL, OTCQX: SPHRY) today announced that its patented nanoparticle formulation, DEP® irinotecan, showed significant efficacy and safety benefits over leading colorectal cancer drugs irinotecan (Camptosar®) and cetuximab (Erbitux®), in the irinotecan-refractory HT-29 human colon cancer model.

GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company dedicated to the discovery and development of innovative therapeutic and diagnostic solutions in metabolic and liver related diseases, today announced the launch of a combination program to identify new treatment options for NASH, using elafibranor as backbone therapy.

Further to its press releases dated April 30, 2019 and April 14, 2019, DionyMed Brands Inc. is providing an update with respect to the previously announced delay in the filing of its annual financial statements for the year ended December 31, 2018 and the management cease trade order issued by the British Columbia Securities Commission on May 2, 2019.

It was a very significant week for Novadoz Pharmaceuticals, the U.S sales & marketing affiliate of The MSN Group based in Hyderabad, India.

ORIC Pharmaceuticals, a privately held, clinical-stage oncology company focused on making cancer treatments more effective by addressing mechanisms of resistance, announced that Jacob Chacko, MD, Chief Executive Officer, will present and host one-on-one investor meetings at the Jefferies 2019 Global Healthcare Conference held June 4-7th at the Grand Hyatt in New York.

Pharmaceutical Product Development, LLC won multiple honors in the annual PharmaTimes Clinical Researcher of the Year competitions, with 16 PPD clinical research professionals recognized by industry peers for their expertise in the enterprise of drug development.

The American Association of Kidney Patients and the George Washington University School of Medicine & Health Sciences Division of Kidney Diseases and Hypertension hosted the Inaugural Global Summit on Innovations in Patient-Centered Kidney Care on May 21-23, 2019 at the George Washington University campus in Washington, D.C. AAKP is the largest and oldest fully independent patient education and advocacy organization in the United States.